Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.140
-0.500-2.83%
Volume:1.44M
Turnover:24.56M
Market Cap:17.60B
PE:-19.70
High:17.630
Open:17.460
Low:17.030
Close:17.640
52wk High:34.820
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:0.88
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.54
PE(LYR):-19.70
PS:4.98

Loading ...

BRIEF-Shanghai Junshi Biosciences Says Toripalimab Met Primary Endpoint

Reuters
·
May 26

JUNSHI BIO’s Toripalimab Hits Primary Endpoints in Phase III NEOTORCH Trial for Stage II-III NSCLC

Bulletin Express
·
May 26

JUNSHI BIO (01877): Phase III Study of Toripalimab with Chemotherapy in Perioperative Treatment for Resectable Stage II-III Non-Small Cell Lung Cancer Meets Primary Endpoints in Final Analysis

Stock News
·
May 26

Shanghai Junshi Biosciences - Toripalimab as Perioperative Treatment for Resectable Stage Ii-Iii Nsclc- Patients Met Primary Endpoint

THOMSON REUTERS
·
May 26

Junshi Biosciences Gets Nod for New Indication for Toripalimab; Shares Down 4%

MT Newswires Live
·
May 22

Shanghai Junshi Biosciences - Approval of Supplemental New Drug Application of Toripalimab

THOMSON REUTERS
·
May 21

Stock Track | JUNSHI BIO Soars 5.23% Intraday on Strong Q1 Earnings Showing Revenue Up 45% and Net Loss Narrowing Over 90%

Stock Track
·
May 11

JUNSHI BIO Nears Profitability, Yet Secondary Market Remains Skeptical: Can It Achieve Critical Valuation Rebound?

Stock News
·
Apr 29

Stock Track | Junshi Bio Soars 5.06% Intraday on ESOP Approval and Q1 Financial Results

Stock Track
·
Apr 28

JUNSHI BIO Shares Climb Over 3% Following Earnings Report

Stock News
·
Apr 28

BRIEF-Shanghai Junshi Biosciences Posts Quarterly Net Loss Attributable RMB20.6 Million

Reuters
·
Apr 27

Shanghai Junshi Biosciences - Qtrly Operating Income RMB726.3 Mln

THOMSON REUTERS
·
Apr 27

Junshi Bio Proposes Adoption of 2026 A-Share Employee Stock Ownership Scheme

Stock News
·
Apr 27

Junshi Bio Board Clears Q1-2026 Report and Unveils New A-Share Employee Stock Ownership Plan

Bulletin Express
·
Apr 27

君实生物2025年收入接近25亿元 核心管线拓展助力亏损明显收窄

Bulletin Express
·
Apr 27

Daily Stake Changes for April 23: Four Firms Including Junshi Bio Plan Reductions, Guochuang Hi-Tech Announces Increase (Table)

Deep News
·
Apr 23

Junshi Bio: Shanghai Tanying Targets ≤2% Block Trade Exit; Ex-Director’s Spouse Plans Minor Sell-Down

Bulletin Express
·
Apr 23

Shanghai Junshi Biosciences -Shanghai Tanying Plans to Reduce Its Holdings of Co's Shares by No More Than 20.5 Mln Shares Through Block Trading

THOMSON REUTERS
·
Apr 23

BNP PARIBAS SA Reduces Stake in Junshi Bio by 510,200 Shares at HK$27.6 Each

Stock News
·
Apr 23

BNP PARIBAS SA Reduces Stake in Junshi Bio by 1.126 Million Shares at HK$26.31 Each

Stock News
·
Apr 20